Literature DB >> 1620812

Type II essential mixed cryoglobulinaemia: presentation, treatment and outcome in 13 patients.

A H Frankel1, D R Singer, C G Winearls, D J Evans, A J Rees, C D Pusey.   

Abstract

The long-term clinical course of patients with primary Type II essential mixed cryoglobulinaemia is unclear as many reports fail to separate this group from patients with Type III disease. We have reviewed 13 patients with Type II essential mixed cryoglobulinaemia who presented to the Hammersmith Hospital between 1976 and 1990. All patients had a cryoglobulin level greater than 0.1 mg/ml (range 0.27-6.50 mg/ml), and characterization of the cryoglobulin in all cases revealed the presence of a monoclonal IgM kappa component with rheumatoid factor activity together with polyclonal IgG. All patients had evidence of activation of the classical pathway of complement with greatly reduced levels of C4, while C3 levels were moderately reduced in three patients. All patients had skin disease and joint symptoms were reported by nine patients, with erosive arthritis in one. Eight patients had peripheral sensorimotor neuropathy. Renal disease was observed in 10 patients, manifesting as raised creatinine level, proteinuria or haematuria. Renal tissue was examined in eight patients: in six the appearances were those of a mesangiocapillary glomerulonephritis Type I while in the other two patients there was a mesangioproliferative glomerulonephritis, in one diffuse and in the other focal and segmental. Glomerular capillary 'hyaline thrombi' were found in six biopsies, extracapillary proliferation was found in three and evidence of vasculitis was found in all eight. Liver biopsy showed macronodular cirrhosis in one patient, while a second with recurrent episodes of jaundice showed only chronic inflammatory changes. No patient was positive for hepatitis B surface antigen; however one patient had low titre anti-hepatitis B surface antibody. Normochromic normocytic anaemia was present in nine patients. Bone marrow examination was carried out in 13 patients at presentation to our unit: 10 showed no evidence of a lymphoproliferative disorder, while three suggested the presence of a non-Hodgkin's lymphoma (some years after original presentation in all three). Unusual clinical features included one patient with retinal vasculitis and one patient with severe pulmonary haemorrhage.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1620812

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  9 in total

Review 1.  The complexity of an overlap type resistant cryoglobulinemia: a case report and review of the literature.

Authors:  Milena Tocut; Ziv Rozman; Alexander Biro; Asher Winder; Amir Tanay; Gisele Zandman-Goddard
Journal:  Clin Rheumatol       Date:  2019-01-10       Impact factor: 2.980

2.  Cyclophosphamide therapy in a patient with membranoproliferative glomerulonephritis and essential mixed cryoglobulinaemia.

Authors:  M Abu-Shakra; M J Hausmann; L Kachko; D Flusser; D Buskila; S Sukenik
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 3.  Vth International Symposium on Sjögren's syndrome. Clinical aspects and therapy.

Authors:  R I Fox
Journal:  Clin Rheumatol       Date:  1995-07       Impact factor: 2.980

Review 4.  Benefits and limitations of plasmapheresis in renal diseases: an evidence-based approach.

Authors:  Sanjeev Baweja; Kate Wiggins; Darren Lee; Susan Blair; Margaret Fraenkel; Lawrence P McMahon
Journal:  J Artif Organs       Date:  2010-12-10       Impact factor: 1.731

5.  Hepatitis C infection and chronic renal diseases.

Authors:  Aline Gonzalez Vigani
Journal:  Hepatol Int       Date:  2012-03-15       Impact factor: 6.047

6.  Acute type II cryoglobulinaemic vasculitis mimicking atherosclerotic peripheral vascular disease.

Authors:  A Saeed; M Khan; S Irwin; A Fraser
Journal:  Ir J Med Sci       Date:  2008-08-19       Impact factor: 1.568

7.  Deterioration of mixed cryoglobulinemia during treatment with interferon-alpha-2a.

Authors:  I Bojić; D Lilić; C Radojcić; P Mijusković
Journal:  J Gastroenterol       Date:  1994-06       Impact factor: 7.527

8.  Survival and Prognostic Factors in Mixed Cryoglobulinemia: Data from 246 Cases.

Authors:  Cesare Mazzaro; Luigino Dal Maso; Endri Mauro; Valter Gattei; Michela Ghersetti; Pietro Bulian; Giulia Moratelli; Gabriele Grassi; Francesca Zorat; Gabriele Pozzato
Journal:  Diseases       Date:  2018-05-03

Review 9.  [Vasculitis associated with viral infections].

Authors:  Pascal Cohen; Loïc Guillevin
Journal:  Presse Med       Date:  2004-11-06       Impact factor: 1.228

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.